番茄社区

ATLANTA 芒鈧�鈥� Five years of breast cancer adjuvant therapy with an aromatase inhibitor, can lead to a 6% to 7% loss of bone mineral density, a trigger for osteoporosis for women who are borderline osteopenic when they begin treatment, investigators reported here.

STANFORD, Calif. - Post-menopausal women who took estrogen alone for more than seven years did not have an increased risk of breast cancer, according to a study of more than 10,000 women ages 50 to 79. The data were dramatically different from a sister study stopped in 2002 of estrogen plus progestin.